Point72 Asset Management L.P. Has $13.49 Million Stock Position in Addus HomeCare Co. (NASDAQ:ADUS)

Point72 Asset Management L.P. lessened its stake in Addus HomeCare Co. (NASDAQ:ADUSFree Report) by 86.4% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 101,375 shares of the company’s stock after selling 644,449 shares during the quarter. Point72 Asset Management L.P. owned 0.56% of Addus HomeCare worth $13,486,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of ADUS. UMB Bank n.a. raised its position in Addus HomeCare by 64.2% during the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock valued at $26,000 after acquiring an additional 88 shares in the last quarter. Quest Partners LLC acquired a new stake in shares of Addus HomeCare in the second quarter worth about $31,000. Farther Finance Advisors LLC boosted its stake in shares of Addus HomeCare by 9,150.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock worth $49,000 after acquiring an additional 366 shares in the last quarter. Innealta Capital LLC bought a new position in shares of Addus HomeCare in the 2nd quarter valued at approximately $44,000. Finally, Sandia Investment Management LP acquired a new stake in Addus HomeCare in the 2nd quarter worth approximately $58,000. Institutional investors and hedge funds own 95.35% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on ADUS. Stephens lifted their target price on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a report on Wednesday, November 6th. StockNews.com downgraded shares of Addus HomeCare from a “buy” rating to a “hold” rating in a report on Tuesday. Oppenheimer lifted their target price on Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research report on Monday, September 23rd. Royal Bank of Canada reissued an “outperform” rating and set a $136.00 price objective on shares of Addus HomeCare in a report on Thursday, November 14th. Finally, Macquarie reiterated an “outperform” rating and set a $139.00 price target on shares of Addus HomeCare in a research note on Monday, November 4th. One research analyst has rated the stock with a sell rating, one has given a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $131.63.

Read Our Latest Stock Analysis on ADUS

Addus HomeCare Trading Up 0.4 %

NASDAQ ADUS opened at $120.74 on Friday. The firm has a market cap of $2.19 billion, a price-to-earnings ratio of 27.63, a PEG ratio of 2.14 and a beta of 1.01. The company has a 50 day moving average of $126.26 and a 200-day moving average of $123.97. Addus HomeCare Co. has a 1-year low of $85.94 and a 1-year high of $136.12.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last issued its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.28 by $0.02. The business had revenue of $289.80 million for the quarter, compared to analyst estimates of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.03 earnings per share. On average, analysts forecast that Addus HomeCare Co. will post 4.58 earnings per share for the current year.

Insider Activity

In other Addus HomeCare news, CEO R Dirk Allison sold 12,500 shares of Addus HomeCare stock in a transaction on Monday, November 25th. The shares were sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the completion of the sale, the chief executive officer now owns 141,897 shares of the company’s stock, valued at approximately $17,476,034.52. The trade was a 8.10 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Esteban Lopez sold 500 shares of the company’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the sale, the director now owns 3,366 shares of the company’s stock, valued at $429,165. This represents a 12.93 % decrease in their position. The disclosure for this sale can be found here. Insiders own 4.60% of the company’s stock.

Addus HomeCare Company Profile

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Featured Stories

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.